VBI Vaccines Inc (VBIV) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
VBI Vaccines Inc. has launched a $2 million registered direct offering, priced according to Nasdaq rules, involving the sale of over 2.2 million common shares or equivalent pre-funded warrants, alongside a concurrent private placement of unregistered warrants. These warrants are immediately exercisable and set to expire in five years. The company aims to use the proceeds for working capital and general corporate purposes, with the offering set to close by April 11, 2024, pending customary conditions.
For further insights into VBIV stock, check out TipRanks’ Stock Analysis page.